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1 Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium 2 Hospital Hygiene Team, Queen Astrid Military Hospital, Brussels, Belgium 3 Burn Centre, Queen Astrid Military Hospital, Brussels, Belgium Background: Worldwide MRSA infections pose lifethreatening problems among critically ill and elderly. In Belgium the proportion of MRSA/MSSA is 23%, increasing to 35% on Intensive Care Units (ICU). Seen the consequences on morbidity, mortality and cost anti-nosocomial infection strategies are implemented. Collecting and analyzing those data is essential for evaluating and monitoring the situation.
Methods: At admission all patients are systematically screened by nasal and peri-anal/or groin region. The swabs are cultured on Chapman medium and consecutively put on Vitek for antibiotic-susceptibility testing. During hospitalization a screening is done two times weekly.
Results: From January 2002 till December 2007, 703 patients were admitted at our ICU and 1494 at our Medium Care Unit (MCU). Nasal swabs showed to be the best screening sampling procedure. The mean MRSA positive carriage at ICU admission is 1.5%. An increased trend was observed since 2004 (1 to 4%). At the MCU however a remarkably lower mean admission incidence of 0.5% was observed, with also the same trend for increase since 2004 (0.1 to 0.5). The nosocomially acquired MRSA infection rate is 5% on the ICU and 4% on the MCU. The higher incidence at the ICU admission is probably due to the fact that this patient population includes patients who are referred from another ICU, beside two other risk factors in this population, the age and often a marginal origin from a social-economic lower class.
Conclusion: We observe a trend for increase the last 3 years which reflects the presence of MRSA in the community. This increase however is in contrast with the recently reported decrease of MRSA nosocomial infections in the global Belgian hospitalization population. Our nosocomial infection rate stayed at the same level and warrants an improved infection control in the Background: Emergence and spread of MDROs are among the most important global health threats. Surveillance of these pathogens helps to generate local data, to formulate specific infection control procedures. This study was conducted to describe risk factors for acquiring MDRO,their antimicrobial susceptibility pattern, classifying type of ESBL produced using molecular methods in representative E. coli and Klebsiella spp.
Methods: Consecutive strains resistant to third generation cephalosporins from HAI/CAI infection were included in the study. A proforma was used for risk factor analysis. Antibiotic susceptibility pattern was determined by Kirby-Bauer disk diffusion method. In 20 strains phenotypic, ESBL detection using cefotaxime, ceftazidime with clavulanic acid by double disk synergy test & E-test (AB. Biodisk, Sweden) was done & genotypic characterisation was done by PCR for TEM, CTX-M, SHV genes.
Results: Among 254 patients enrolled (91%HAI & 9% CAI) 258 MDRO'S were isolated. Gram-negative bacilli (84%) were predominant-Enterobacteriaceae (61%) and non -enterobacteriaceae (23%) 14.7% of which are pan drug resistant. No VRE was detected. Diabetes mellitus (43%) was the commonest comorbid condition,92 patients had an indwelling urinary catheter, 80 a central venous catheter, 87 mechanical ventilation, 21 had undergone dialysis. Cefotaxime clavulanic acid detected 75% of ESBL, Ceftazidime clavulanic acid detected 55%. Among 15 strains detected as ESBL phenotypically 14 were ESBL genotypically CTX-M is the predominant 93.3% ESBL genotype. TEM was detected in 80% of isolates, However no SHV was detected.
Conclusion: HAI account for majority of MDRO,most Gram-negative Enterobacteriaceae. Majority of ESBL's were detected when cefotaxime with clavulanic acid disc than when ceftazidime clavulanic acid was used. CTX-M is the predominant genotype. 
